You have 9 free searches left this month | for more free features.

IL-1 Blockade

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Heart Failure Trial in Richmond (Anakinra)

Recruiting
  • Heart Failure
  • Richmond, Virginia
    Virginia Commonwealth University
Sep 25, 2023

Interleukin-6 Inhibition, Physical Stress, Appetitive Behavior Trial in Copenhagen Ø (Tocilizumab Injectable Product, Saline

Completed
  • Interleukin-6 Inhibition
  • +2 more
  • Tocilizumab Injectable Product
  • Saline 0.9% 100 ml NaCl 0.9% will be infused over 1 hour
  • Copenhagen Ø, Denmark
    Center For Physical Activity (CFAS)
Aug 19, 2022

IL-13 Blockade and Airway Autoimmunity in Asthma

Not yet recruiting
  • Airway Auto Immunity in Asthma
    • (no location specified)
    Sep 30, 2022

    Psoriasis Vulgaris Trial in San Francisco (Tildrakizumab)

    Recruiting
    • Psoriasis Vulgaris
    • Tildrakizumab
    • San Francisco, California
      University of California, San Francisco
    Jun 2, 2022

    Nasal IL 1 Beta ,IL 3 Level and Their Effects in COPD Patients

    Not yet recruiting
    • Copd Patients
    • IL B,IL 3 in nasal swap and serum
    • (no location specified)
    Aug 4, 2023

    Myeloma Trial in Houston (Fludarabine phosphate, Cyclophosphamide, NY-ESO-1 TCR/IL-15 NK)

    Not yet recruiting
    • Myeloma
    • Fludarabine phosphate
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 27, 2023

    Breast Cancer Trial in Ottawa, Toronto (Arm A: Cemiplimab, Arm B: Cemiplimab + Dupilumab)

    Not yet recruiting
    • Breast Cancer
    • Arm A: Cemiplimab, Arm B: Cemiplimab + Dupilumab
    • Ottawa, Ontario, Canada
    • +1 more
    Jul 22, 2023

    Esophageal Carcinoma, Neoadjuvant Immunotherapy Trial in Beijing (PD-1 blockade, Albumin paclitaxel, Carboplatin/Nedaplatin)

    Recruiting
    • Esophageal Carcinoma
    • Neoadjuvant Immunotherapy
    • PD-1 blockade
    • +2 more
    • Beijing, Beijing, China
      Qin li
    Mar 8, 2023

    Nausea With Vomiting Chemo-Induced Trial in Wuhan (Ondansetron every 3 weeks, Aprepitant, Dexamethasone)

    Not yet recruiting
    • Nausea With Vomiting Chemotherapy-Induced
    • Ondansetron every 3 weeks
    • +3 more
    • Wuhan, Hubei, China
      Hubei Cancer Hospital
    Oct 8, 2023

    Post-Traumatic Headache Trial in West Haven (Bupivacaine Injection)

    Recruiting
    • Post-Traumatic Headache
    • Bupivacaine Injection
    • West Haven, Connecticut
      VA Connecticut Healthcare System
    Sep 28, 2023

    Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients Trial in Assiut (Quantitative Real Time Polymerase chain

    Recruiting
    • Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients
    • Quantitative Real Time Polymerase chain reaction (qRT-PCR)
    • ELISA and colorimeter
    • Assiut, Egypt
      Biochemistry department,Faculty of medicine
    Oct 10, 2023

    Digestive System Cancers Trial in Beijing (KN046, Regorafenib, Apatinib)

    Recruiting
    • Digestive System Cancers
    • Beijing, China
      Peking University Cancer Hospital
    Oct 25, 2023

    Periodontitis Trial in Rize (biochemical analysis)

    Completed
    • Periodontitis
    • biochemical analysis
    • Rize, Turkey
      Recep Tayyip Erdogan University
    Oct 18, 2023

    PD-1 Checkpoint Blockade Using Deep Learning Analysis of Imaging

    Completed
    • Non-small Cell Lung Cancer (NSCLC)
      • Nîmes, France
        Jean-Paul BEREGI
      Jan 25, 2023

      LAD1 Trial run by the NIAID (Ustekinumab)

      Recruiting
      • LAD1
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 24, 2023

      Acne Vulgaris, Vitamin D Trial in Jakarta Pusat (combination oral and topical vitamin D, oral and topical cholecalciferol, oral

      Enrolling by invitation
      • Acne Vulgaris
      • Vitamin D
      • combination oral and topical vitamin D
      • +2 more
      • Jakarta Pusat, DKI Jakarta, Indonesia
        RSUPN Dr. Cipto Mangunkusumo
      Mar 4, 2023

      Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, Relapsed Hodgkin's Disease, Adult Trial in Leon (Brentuximab Vedotin 50 MG

      Recruiting
      • Hodgkin Lymphoma
      • +2 more
      • Brentuximab Vedotin 50 MG [Adcetris]
      • Leon, Guanajuato, Mexico
        Hospital Regional Alta Especialidad Bajio
      Oct 24, 2022

      Esophagus Cancer, Bladder Cancer, Liver Cancer Trial (Intravenous injection of P-IL-2, P-IL-2 plus Anti-PD-1 Monoclonal

      Not yet recruiting
      • Esophagus Cancer
      • +4 more
      • Intravenous injection of P-IL-2
      • P-IL-2 plus Anti-PD-1 Monoclonal Antibody
      • (no location specified)
      Apr 24, 2023

      Cardiac Sarcoidosis Trial in Ann Arbor, Richmond (Anakinra)

      Recruiting
      • Cardiac Sarcoidosis
      • Ann Arbor, Michigan
      • +1 more
      Nov 8, 2021

      Locally Advanced Pancreatic Adenocarcinoma Trial in Houston (SD-101, pebrolizumab)

      Recruiting
      • Locally Advanced Pancreatic Adenocarcinoma
      • Houston, Texas
        MD Anderson Cancer Center
      Nov 18, 2022

      Endometrial Tumors, Endometrial Cancer Trial in Seoul (Nivolumab)

      Not yet recruiting
      • Endometrial Neoplasms
      • Endometrial Cancer
      • Seoul, Korea, Republic of
        Severance Hospital, Yonsei University Health System
      Mar 21, 2023

      Unmethylated Glioblastoma Trial in Saint Louis (Personalized Neoantigen DNA vaccine, Retifanlimab, TDS-IM v 2.0 electroporation

      Not yet recruiting
      • Unmethylated Glioblastoma
      • Personalized Neoantigen DNA vaccine
      • +2 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      Feb 14, 2023

      Oral Squamous Cell Carcinoma Trial in Wuhan (Camrelizumab, Camrelizumanb plus TPF)

      Active, not recruiting
      • Oral Squamous Cell Carcinoma
      • Wuhan, Hubei, China
        Hospital of Stomatology, Wuhan University
      Aug 17, 2022

      Rectal Cancer Trial in Frankfurt (drug, radiation, procedure)

      Recruiting
      • Rectal Cancer
      • Kineret 100 MG in 0.67 ML Prefilled Syringe
      • +3 more
      • Frankfurt, Germany
        University Hospital Goethe University Frankfurt
      Aug 23, 2022